Nuzenio

Patrick Soon

Patrick Soon news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

ImmunityBio Founder Reaffirms Grip As Stock Plunges In Worst Selloff Since 2024 After Massive Rally - StocktwitsStocktwits · Sat, 08 Aug 2026 09:21:50 GMT IBRX Stock Rises Overnight: Investors Eye FDA Workshop On Anktiva After Exclusive Japan BCG Deal - StocktwitsStocktwits · Sat, 08 Aug 2026 08:26:22 GMT ImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken In - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 03:42:41 GMT IBRX Stock Extends Rally: Founder Flags Fresh Bull Case For Anktiva On Breast Cancer Immune Signal - StocktwitsStocktwits · Fri, 07 Aug 2026 13:12:20 GMT ImmunityBio (IBRX) group led by Soon-Shiong holds 64.8% stake - Stock TitanStock Titan · Thu, 06 Aug 2026 22:51:11 GMT Patrick Soon-Shiong: Great to See That Novartis Drug With Lu177 Received Expanded Approval - OncodailyOncodaily · Thu, 06 Aug 2026 19:46:20 GMT Patrick Soon-Shiong: So Excited That UAE EDE Took the Lead to Authorize the Broadest Aproval for ANKTIVA - OncodailyOncodaily · Fri, 31 Jul 2026 07:00:00 GMT PATRICK SOON-SHIONG - Orange County Business JournalOrange County Business Journal · Mon, 27 Jul 2026 07:41:14 GMT

Timeline

Sat, 08 Aug 2026 09:21:50 GMTImmunityBio Founder Reaffirms Grip As Stock Plunges In Worst Selloff Since 2024 After Massive Rally - Stocktwits

Sat, 08 Aug 2026 08:26:22 GMTIBRX Stock Rises Overnight: Investors Eye FDA Workshop On Anktiva After Exclusive Japan BCG Deal - Stocktwits

Sat, 08 Aug 2026 03:42:41 GMTImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken In - The National Law Review

Fri, 07 Aug 2026 13:12:20 GMTIBRX Stock Extends Rally: Founder Flags Fresh Bull Case For Anktiva On Breast Cancer Immune Signal - Stocktwits

Thu, 06 Aug 2026 22:51:11 GMTImmunityBio (IBRX) group led by Soon-Shiong holds 64.8% stake - Stock Titan

Thu, 06 Aug 2026 19:46:20 GMTPatrick Soon-Shiong: Great to See That Novartis Drug With Lu177 Received Expanded Approval - Oncodaily

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

Connected entities

Shiong8 live mentions After Massive Rally2 live mentions Stocktwits Stocktwits2 live mentions Investors Eye FDA2 live mentions Workshop On Anktiva2 live mentions After Exclusive Japan2 live mentions Stocktwits IBRX Stock2 live mentions Speak2 live mentions The National Law2 live mentions Founder Flags Fresh2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Patrick Soon.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.